In the ovarian cancer cell line A2780MNU1 that is MMR deficient, re-expression of MLH1 by gene transfection resulted in marked reductions of cell survival and proliferation, with higher percentage of cells displaying active caspase 3 after drug treatment [26]. The gene discussed is CASP3; the disease is ovarian carcinoma.